BNP Paribas Asset Management
NVAX icon

BNP Paribas Asset Management’s Novavax NVAX Stock Holding History

BNP Paribas Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Sell
2,021
-60,432
-97% -$542K ﹤0.01% 2064
2026
Q1 		$508K Buy
62,453
+60,823
+3,731% +$551K ﹤0.01% 1249
2025
Q4 		$11K Buy
1,630
+344
+27% +$2.59K ﹤0.01% 2126
2025
Q3 		$11K Hold
1,286
– – ﹤0.01% 1608
2025
Q2 		$8K Buy
+1,286
New +$8.52K ﹤0.01% 1856
2021
Q4 		– Sell
-1,228
Closed -$255K – 940
2021
Q3 		$255K Sell
1,228
-899
-42% -$198K ﹤0.01% 851
2021
Q2 		$452K Buy
+2,127
New +$390K ﹤0.01% 821
2016
Q2 		– Sell
-5,652
Closed -$583K – 1102
2016
Q1 		$583K Sell
5,652
-48,697
-90% -$5.22M ﹤0.01% 898
2015
Q4 		$9.12M Sell
54,349
-6,507
-11% -$1M 0.08% 321
2015
Q3 		$8.61M Sell
60,856
-26,703
-30% -$5.99M 0.08% 335
2015
Q2 		$19.5M Sell
87,559
-15,681
-15% -$2.76M 0.16% 182
2015
Q1 		$17.1M Sell
103,240
-86,734
-46% -$14.1M 0.13% 227
2014
Q4 		$22.5M Sell
189,974
-2,040
-1% -$213K 0.18% 161
2014
Q3 		$16M Buy
192,014
+13,342
+7% +$1.21M 0.13% 208
2014
Q2 		$16.5M Buy
178,672
+71,226
+66% +$6.26M 0.13% 208
2014
Q1 		$9.73M Buy
107,446
+49,164
+84% +$5.49M 0.07% 289
2013
Q4 		$5.97M Buy
+58,282
New +$4.12M 0.04% 362

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

BNP Paribas Asset Management's NVAX Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Novavax (NVAX) stake by 97% in Q2 2026, selling an estimated $542K and leaving 2,021 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

BNP Paribas Asset Management first reported a position in NVAX in Q4 2013 and has held it in 17 quarters since. The position peaked at $22.5M in Q4 2014. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • BNP Paribas Asset Management held 2,021 shares of Novavax worth $19K as of Q2 2026.
  • BNP Paribas Asset Management sold 60,432 Novavax shares in Q2 2026, an estimated $542K.
  • Novavax made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2064 holding.
  • BNP Paribas Asset Management first reported a position in Novavax in Q4 2013 and has held it in 17 quarters since.
  • BNP Paribas Asset Management's Novavax position peaked at $22.5M in Q4 2014.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.